Patents by Inventor Jacqueline C. Bussolari

Jacqueline C. Bussolari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators
    Patent number: 8278268
    Abstract: Combination therapy comprising PPAR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.
    Type: Grant
    Filed: October 24, 2007
    Date of Patent: October 2, 2012
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Jacqueline C. Bussolari, Xiaoli Chen, Bruce R. Conway, Keith T. Demarest, Hamish N. M. Ross, Rafael Severino
  • Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators
    Patent number: 8183213
    Abstract: Combination therapy comprising RXR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.
    Type: Grant
    Filed: October 24, 2007
    Date of Patent: May 22, 2012
    Assignee: Ortho McNeil Pharmaceutical, Inc.
    Inventors: Jacqueline C. Bussolari, Xiaoli Chen, Bruce R. Conway, Keith T. Demarest, Hamish N. M. Ross, Rafael Severino
  • COMBINATION THERAPY COMPRISING GLUCOSE REABSORPTION INHIBITORS AND RETINOID-X RECEPTOR MODULATORS
    Publication number: 20090075864
    Abstract: Combination therapy comprising RXR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.
    Type: Application
    Filed: October 24, 2007
    Publication date: March 19, 2009
    Inventors: Jacqueline C. Bussolari, Xiaoli Chen, Bruce R. Conway, Keith T. Demarest, Hamish N.M Ross, Rafael Severino
  • Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators
    Patent number: 6838442
    Abstract: Combination therapy comprising RXR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: January 4, 2005
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Jacqueline C. Bussolari, Xiaoli Chen, Bruce R. Conway, Keith T. Demarest, Hamish N. M. Ross, Rafael Severino
  • Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators
    Publication number: 20030199557
    Abstract: Combination therapy comprising PPAR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.
    Type: Application
    Filed: March 24, 2003
    Publication date: October 23, 2003
    Inventors: Jacqueline C. Bussolari, Xiaoli Chen, Bruce R. Conway, Keith T. Demarest, Hamishi N.M. Ross, Rafael Severino
  • Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators
    Publication number: 20030195235
    Abstract: Combination therapy comprising RXR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.
    Type: Application
    Filed: February 24, 2003
    Publication date: October 16, 2003
    Inventors: Jacqueline C. Bussolari, Xiaoli Chen, Bruce R. Conway, Keith T. Demarest, Hamish N.M. Ross, Rafael Severino
  • Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators
    Publication number: 20030055091
    Abstract: Combination therapy comprising RXR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.
    Type: Application
    Filed: April 3, 2002
    Publication date: March 20, 2003
    Inventors: Jacqueline C. Bussolari, Xiaoli Chen, Bruce R. Conway, Keith T. Demarest, Hamish N.M. Ross, Rafael Severino
  • Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators
    Publication number: 20030045553
    Abstract: Combination therapy comprising PPAR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.
    Type: Application
    Filed: April 3, 2002
    Publication date: March 6, 2003
    Inventors: Jacqueline C. Bussolari, Xiaoli Chen, Bruce R. Conway, Keith T. Demarest, Hamish N.M. Ross, Rafael Severino